Thermo Fisher Scientific
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Thermo Fisher Scientific 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About TMO
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings.
CEOMarc N. Casper
CEOMarc N. Casper
Employees125,000
Employees125,000
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded1956
Founded1956
Employees125,000
Employees125,000
TMO Key Statistics
Market cap188.89B
Market cap188.89B
Price-Earnings ratio28.00
Price-Earnings ratio28.00
Dividend yield0.34%
Dividend yield0.34%
Average volume2.05M
Average volume2.05M
High today$502.39
High today$502.39
Low today$486.95
Low today$486.95
Open price$488.47
Open price$488.47
Volume1.68M
Volume1.68M
52 Week high$627.88
52 Week high$627.88
52 Week low$385.46
52 Week low$385.46
TMO News
Simply Wall St 3h
Thermo Fisher Scientific Unveils Glow-in-the-Dark Bottles and Opens Carbon Neutral Facilityrecently opened a new, carbon-neutral manufacturing facility in North Carolina and launched the innovative GloWyld collection through its Nalgene Outdoor unit....
Simply Wall St 1d
Thermo Fisher Scientific Rebounds 24% as Investors Reassess Prospects in 2025Advertisement Trying to Decide What to Do With Thermo Fisher Scientific Stock? Let’s talk about where Thermo Fisher Scientific sits right now, especially if y...
Benzinga 3d
Thermo Fisher Positioned As Biopharma's Partner Of ChoiceCould Thermo Fisher Scientific Inc. TMO be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betti...
Analyst ratings
80%
of 30 ratingsBuy
80%
Hold
20%
Sell
0%
More TMO News
TipRanks 4d
Thermo Fisher initiated with an Outperform at William BlairWilliam Blair initiated coverage of Thermo Fisher (TMO) with an Outperform rating and no price target The firm believes the company’s “one-stop-shop” pharma par...
People also own
Based on the portfolios of people who own TMO. This list is generated using Robinhood data, and it’s not a recommendation.